Medicure Inc.

11/05/2021 | Press release | Distributed by Public on 11/05/2021 04:01

Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint - Form 6-K